65,437 trials
Metastatic Breast Cancer · Locally Advanced Breast Cancer
Primary: Overall Response Rate (ORR) in Participants With HER2-negative MBC (Part A and Part B) — 35; 5 percentage of participants
Vitamin C Deficiency
Primary: To Assess Between-group Differences in the Change in Blood Vitamin C Levels From Baseline to Day 28 — 0.365; 0.133 mg/dL — p=0.03
Obesity · Overweight
Primary: Percentage Change in Body Weight — -15.8; -2.2 Percentage (%) change in body weight — p=<0.0001
Vancomycin-Resistant Enterococcus
Primary: Vancomycin-Resistant Enterococcus (VRE) Colonization — 0; 0; 30; 33 participants with VRE colonization — p=0.671
COPD
Primary: Change in Percentage Ventilated Defect Percent (VDP) — -0.14 % change in VDP
Opioid Use · Stimulant Use
Primary: Participant Confidence Using Harm Reduction Techniques at Baseline — 5.43; 6.61 score on a scale
Advanced Renal Cell Carcinoma
Primary: Number of Participants Who Submitted at Least One Carevive Survey — 13 Participants
X-linked Hypophosphatemia · Hypophosphatemic Rickets · Hypophosphatemic Rickets, X-Linked Dominant
Primary: Change in Serum Phosphate in Adults and Children With XLH Between Baseline and 12 Months — 2.6; 2.1 mg/dl — p=0.318
Lyme Disease
Primary: Percentage of Participants With at Least 1 Local Reaction of Any Grade for up to 7 Days Following Study Vaccination 1 — 80.8; 34.8; 80.6; 14.6 Percentage of participants
Spinal Cord Injuries
Primary: Change From Baseline in VO2 Peak (L/Min) Achieved During Arm Ergometry Exercise Alone — 0.11; 0.09 L/min
Idiopathic Pulmonary Fibrosis
Primary: The Percent Change in Daytime Cough Frequency (Coughs Per Hour) — -40.8; -4.3 % change
Pain · Function · Anxiety
Primary: Pain Intensity — 4.1; 3.9; 3.9; 3.4 units on a scale
Prostate Cancer · Head and Neck Cancers · Upper Abdomen Cancers
Primary: Ratio of Standard CBCT to Research CBCT HU Error in Photon Therapy Participants — 1.768 Ratio (unitless) — p=0.0001
Healthy
Primary: Stop-and-go (SAG) Ability — -0.04 Time (s)
Healthy
Primary: Area Under the Concentration-time Curve of Ethinylestradiol (EE) in Plasma at Steady State Over a Uniform Dosing Interval τ (AUCτ,ss) — 916.63; 942.17…